Back

Assessment of the safety and performance of a novel RF balloon catheter system to isolate pulmonary veins: results of the multicenter AF-FICIENT 1 Trial

17 March 2019 (15:00 - 15:10)
Organised by:
Congress Presentation Part of: Late-breaking trials 1 Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Amin Al-Ahmad

St. David's Medical Center, Austin (United States of America)

10 More presentations in this session

Presentation thumbnail
A randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation:The CIRCA-DOSE Study
Doctor J. Andrade (Vancouver, CA)
Slides Video
Presentation thumbnail
CIRCA-DOSE Study - Discussion
Professor D. Scherr (Graz, AT)
Slides Video
Presentation thumbnail
Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - AVATAR AF
Professor P. Kanagaratnam (London, GB)
Slides Video
Presentation thumbnail
Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - Discussion
Professor J. Merino (Madrid, ES)
Slides Video
Presentation thumbnail
Quality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation catheter: results from the multicenter GOLD AF registry
Professor L. Boersma (Nieuwegein, NL)
Slides Video

Access the full session

Session thumbnail
Late-breaking trials 1

The Event

Event poster

EHRA 2019

17 March 2019 15:00 CET
You may be interested in
thumbnail
Congress Presentation
First insight into a novel irrigated radiofrequency ablation balloon
25 April 2021
thumbnail
Congress Session
Catheter ablation procedural outcome
30 March 2025
thumbnail
Congress Presentation
Pulmonary vein isolation using a novel dual-energy (RF-PF) ablation catheter: procedural effectiveness and safety in a real-world cohort
13 April 2026
thumbnail
Congress Presentation
Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources